Licensing

Five things for pharma marketers to know: Wednesday, March 29, 2017

Five things for pharma marketers to know: Wednesday, March 29, 2017

By

A panel recommends the U.S. government license a hepatitis-C therapy; the FDA approves Roche MS drug; new eczema drug to cost $37,000 per year